Osprey Intel LLC

Private capital investors waste weeks on fragmented research, stitching together data from dozens of sources to build investment theses. Traditional consulting takes 12-16 weeks and costs $50K+, while DIY approaches burden teams with data wrangling instead of decision-making.

Osprey Intel solves this with purpose-built vertical AI agents that compress investment diligence from weeks to days, delivering interactive, auditable research that integrates directly into investment committee workflows.

  • Market Position: Vertical AI agent capturing application layer value in the $2B+ investment research services market
  • Speed Advantage: 3x analytical depth in 3-4 weeks vs. 12-16 weeks traditional consulting
  • Workflow Integration: Interactive apps replace static PDFs, enabling real-time exploration during IC meetings
  • Proven Traction: Validated with tier-1 VCs across Life Sciences, Climate Tech, and expanding verticals

Founders

Photo of José Luis Caraveo III

José Luis Caraveo III
Co‑founder, Osprey Intel LLC

Morgan Stanley Logo Northern Trust Logo LEK Consulting Logo
Photo of Craig D'Cruz

Craig D'Cruz
Co‑founder & Registered Agent

Vanguard Logo Accenture Logo GitHub Logo
View Details →

Company Facts

What we are: Vertical, agentic AI for private capital. TalonStrike orchestrates domain-specific research agents over licensed data (RAG + dual-citation) to produce IC-ready artifacts in days, not weeks.

  • Formation: Member-managed NH LLC (May 30, 2025)
  • Products: Deep Dive decks (six-module standard) and clickable TalonStrike micro-apps; credits bundled with team licenses to sustain attach.
  • Traction (Summer ’25, stealth): Flagship programs with Fall Line Capital, Superluminal Medicines, and Broadview Ventures; major components shipped in ≤1 week; validated attach to live dealflow and IC use.
  • ICP (validated): Lean VC/PE teams (8–12 investors) in Life Sciences & Climate beachheads; buyer = Partner/Principal; champion = Sr. Associate / VP BD; already paying for multiple data/AI tools—Osprey unifies and cites.
  • Customer journey: Land via Deep Dive → expand to $60k/team license with included credits; SLA tiers for speed; channel partners (secondaries platforms, data providers) to originate events.
  • Why now: Private markets need agentic workflows that compress time-to-IC and travel with the deal (interactive, audit-safe, share-safe).
Agentic vertical AI RAG + dual-citation IC-ready micro-apps Days, not weeks

Flagship Engagements

Stealth-mode summer projects; a deep-dive project with Fall Line Capital; plus a two-sprint program with Superluminal Medicines and Broadview Ventures.

Fall Line Capital Logo Superluminal Medicines Logo Broadview Ventures Logo

Who We Serve: Lean Private‑Capital Teams

Small–midsize VCs, PEs, and family offices that need deal screening capacity without adding headcount.

  • Team size: 8–12 investment professionals
  • AUM & checks: $50M+ AUM; $2M–$25M initial checks
  • Focus: niche / frontier areas where ramp‑up is hard
  • Stack: already paying for multiple data/AI tools—Osprey unifies and cites
Capacity, not headcount Dual‑citation outputs Frontier‑ready scaffolds

Technology & Methodology

Agentic vertical AI tuned for private capital. We ingest licensed data, ground models with a retrieval graph, orchestrate domain agents, and ship dual‑cited, IC‑ready artifacts.

Multi‑Model Orchestration

  • Specialized prompts & tools per diligence task (sizing, WTP, regulatory scan).
  • Guardrails: function calling for calculators, tables, and schema‑checked outputs.
  • Latency budget with fallbacks (fast/accurate model pairs).
Artifact TAT: ≤ 7 days Refresh: weekly / on‑event

Licensed Ingestion & Parsing

  • Only licensed feeds + client‑provided docs; public web kept sandboxed.
  • Robust parsing for HTML/PDF/CSV; entity/section tagging at ingest.
  • PII/MNPI pathways disabled by default; contract‑gated if required.
Zero‑shot doc coverage: 95%+ Schema errors < 1%

RAG Graph & Memory

  • Hierarchical chunks + cross‑doc links (companies, products, trials, regs).
  • Dual index: semantic + symbolic (filters on date, source, jurisdiction).
  • Query plans tuned to diligence stage (screen, dive, IC pack).
Hallucination: < 0.5% Recall uplift: +12–18%

Dual‑Citation & Governance

  • Every claim pins to (1) primary source and (2) analyst note/snippet.
  • QA gate: citation presence, link health, and scope conformity.
  • Share‑safe exports (client watermarking, redaction, view‑only links).
Citation coverage: 100% Link rot < 0.5%
Agentic orchestration RAG + memory Dual‑citation Audit‑safe

Private vs. Public Capital Market Needs

Explaining the critical workflow differences that TalonStrike is designed to solve for private capital investors.

Deal Sourcing Workflows

Private Capital: Relies on proprietary networks, thematic thesis mapping, and targeted inbound funnels. Information is fragmented and relationship-driven.
Public Capital: Driven by sell-side research, regulated filings (10-K, 8-K), and predictable earnings calendars. Information is structured and broadly available.

Deal Screening Workflows

Private Capital: Focuses on qualitative signals: thesis fit, team strength, product novelty, and early market validation. Requires synthesizing unstructured data.
Public Capital: Utilizes quantitative factor models, KPI screens (e.g., revenue growth, margins), and consensus estimates. Highly data-driven and automated.

Due Diligence Workflows

Private Capital: A mosaic-building exercise combining expert interviews, analysis of private datasets, competitive intelligence, and regulatory pathway assessment.
Public Capital: Centers on analyzing public filings, alternative data (e.g., credit card transactions, web traffic), and financial modeling based on consensus.

Decision Artifacts

Private Capital: The core deliverable is the Investment Committee (IC) memo—a narrative-driven document supported by a business development (BD) data pack.
Public Capital: The primary artifacts are detailed earnings models, valuation summaries, and research notes published to clients.

Osprey Intel Overview + Timeline

Our origin, traction, and key milestones.

Spring 2025

Foundational First-Year Project (FYP) at Tuck

Project: "Tissue and Organ Engineering: Investor Sentiments and Analysis."
This project, acclaimed by faculty for its high quality and for which we earned top marks, analyzed VC investment trends in regenerative medicine. Workflows and concepts applied in the FYP became the basis for early brainstorming around the initial "Atlas Intel" concept. A white paper based on the deliverable has been submitted for publication to respected journals, including Regenerative Therapy and Cytotherapy.

May 30, 2025

Formation of Osprey Intel LLC

The venture was formally incorporated with the state of New Hampshire, evolving from its original name, "Atlas Intelligence".

Summer 2025

Stealth Summer Projects

Delivered flagship programs and deep dives for three key partners: Fall Line Capital, Superluminal Medicines, and Broadview Ventures.

August 18, 2025

Key Artifact Delivery

Shipped the Congenital Heart Disease (CHD) static deck and the Pediatric Pulmonary Valve (PPV) TalonStrike micro-app suite for Broadview Ventures.

Consolidated Market SizingTAM/SAM/SOM

Triangulated from current PitchBook data and explicit assumptions. We show: project TAM for Deep Dives (by beachhead verticals + add‑ons) and the license SAM/SOM using a conservative “active teams” proxy.

Top‑Down — Beachhead Verticals (deal‑attached projects)

  • Healthtech VC deals: 2024: 849; H1’25: 414.
  • Pharma biotools VC deals: 2024: 282; H1’25: 232.
  • Attach: 20–40%.
  • Per‑project price: $40k–$60k.
2024 actuals: $9.0M–$27.1M (base $17.0M) 2025 run‑rate (H1×2): $10.3M–$31.0M (base $19.4M)
Assumptions

Attach applies only to deals requiring structured market diligence; price band matches our current delivery scope.

Bottom‑Up — License (TalonStrike)

  • Active teams proxy: 1,379 TTM funds (global) × 57.6% NA ⇒ ~794 NA teams.
  • Price: $60k ARR/team.
  • Adoption (24–36 mo): 8–15% ⇒ SOM $3.8M–$7.1M.
  • ICP filter (40–60% of teams): SAM $19.1M–$28.6M; SOM $1.5M–$4.3M.
License SAM (NA): $47.6M ARR License SOM (@8–15%): $3.8M–$7.1M ARR ICP filter (40–60% teams): $19.1M–$28.6M SAM; $1.5M–$4.3M SOM
Assumptions

Using TTM fund count × NA share as a conservative “active teams” proxy. ICP narrows to small–midsize VCs/FOs/PE with 8–12 pros.

PE Buyout Add‑ons (Big Seven)

TTM corporate PE deployment $83.10B (+65.3% YoY). We estimate add‑on diligence demand from this flow.

ScenarioAdd‑on $ (TTM)Approx. Add‑on DealsDive AttachProject TAM
Conservative$33.24B22130%$2.7M
Base$41.55B41540%$8.3M
Aggressive$49.86B66460%$23.9M
Assumptions

Add‑on share (40–60%), avg equity ($75–$150M), attach (30–60%), Deep Dive price ($40–$60k). Tunable per GP.

VC Direct Secondaries & SPVs (US)

US VC direct secondary market midpoint: $61.10B. “Known” platform+provider volumes: $24.70B, of which $19.30B are tender offers (avg $130.0M ⇒ ~85 offers).

SegmentVolume / CountAssumptionsOsprey Project TAM
Platform & small‑block trades$5.40B non‑tender$2–$10M blocks (mid $5M) ⇒ ~540–2,700 events (mid ~1,080); attach 20–40%; price $15–$30k$1.6M–$32.4M (base $6.5M)
Tender offers~85 @ $130.0M avgAttach 30–60%; price $40–$60k$1.0M–$3.1M (base $1.7M)
Combined Secondaries TAM: $2.6M–$35.5M (base $8.2M)

Executive Brief

Executive brief (unchanged core math, client view): Project TAM (services): Beachhead Deep Dives ~$19.4M run‑rate; PE add‑ons ~$8.3M (base). Combined ≈ $27.7M (range $13.0M–$54.9M).

License SAM/SOM (NA): SAM $47.6M; SOM (8–15% adoption) $3.8M–$7.1M. ICP‑narrow SAM $19.1M–$28.6M; SOM $1.5M–$4.3M.

IC takeaway: Treat $3.8–$7.1M SOM as a license wedge; the services TAM ($27.7M base) and secondaries/PE adjacencies create a credible path to materially larger obtainable revenue as modules are productized and attach is sustained.

Interactive Assumptions Tuner

Use the sliders below to adjust the core assumptions and see the TAM/SAM/SOM figures update in real-time.

Beachhead Verticals
30%
$50k
35%
$55k
Healthtech Events: ...
Healthtech TAM: ...
Biotools Events: ...
Biotools TAM: ...
Total Beachhead TAM: ...
PE Buyout Add-ons
50%
$100M
40%
$50k
Add-on Deals: ...
PE Add-on TAM: ...
VC Direct Secondaries
$5.0M
30%
$20k
Platform Events: ...
Platform TAM: ...
Tender TAM (fixed): ...
Combined Secondaries TAM: ...

Executive Brief (Live Total)

The total addressable project market, based on your interactive assumptions.

Combined Project TAM: $...

GTM & Pricing Schematic Dual Engine

High‑margin licenses + repeatable Deep Dive projects attached to deal flow.

Core — $60k/yr

Platform + 1 Deep Dive credit + standard SLA

Pro — $90k/yr

+2 credits, private models, priority SLA

Enterprise — $150k+/yr

6–8 credits, governance, security addenda

  • Projects: VC Deep Dive $40–$60k; PE add‑on diligence $40–$60k (volume: 5‑pack $225k; 10‑pack $430k); Secondaries: blocks $15–$30k; tenders $40–$60k.
  • Design: Land via projects → expand to license; bundle credits to keep attach high.

Competitive Landscape & WTP Anchors WTP/GTM

Positioning (category vs. gap we exploit)

AltStrengthGap we exploit
CI suites (AlphaSense, Tegus)breadth/transcriptsno decision artifacts; limited frontier scaffolds
Life‑sci data/report providersdatasets/reportsstatic PDFs; slow to customize to thesis
DIY BI & docsflexible/cheaptime sink; no dual‑citation governance

WTP anchors (validated/provisional)

  • Projects (per suite): VC Deep Dive $40–$60k; PE add‑on $40–$60k; Secondaries — blocks $15–$30k, tenders $40–$60k.
  • Annual License (Team): $60k (Core) / $90k (Pro) / $150k+ (Enterprise).
  • Annual License (Firm): $90–$150k baseline; scalable by seats & credits.
Blended GM target Yr‑1: 70–75%CAC payback: <6 moNRR >120%

GTM & packaging: Credit‑bundled licenses to keep attach high; PE add‑on packs (example: 5‑pack $225k, 10‑pack $430k).

Demand signals underpinning WTP (sizing modules):
  • Secondaries: Platform/small‑block flow $5.40B (non‑tender). Assumptions $2–$10M blocks (mid $5M) ⇒ ~540–2,700 events; attach 20–40%; price $15–$30k$1.6M–$32.4M TAM (base $6.5M). Tenders ~85; attach 30–60%; $40–$60k$1.0M–$3.1M TAM (base $1.7M).
  • PE add‑ons: Scenario table already embedded (Conservative/Base/Aggressive) to show attach/price sensitivity.

IC takeaway: Price points and pack design are anchored in actual workflow intensity (secondaries, PE add‑ons) and a license‑first margin profile. This is the format ICs expect: market map + value/WTP evidence + packaging (credits/tiers) that supports NRR >120%.

Delivery, Governance & References

Our process for building and governing Osprey Intel LLC: citation-first, licensed-data only, and secure.

Process & SLAs

Our delivery follows a structured path: Intake → Scope → Build → QA (all citations checked) → Client Handoff → Refresh Cadence. We guarantee source trails for all external data.

Governance

We use only licensed data sources, ensuring compliance. All client deliverables are architected for secure sharing, with no PII/MNPI handled unless contractually required.